| [1] |
ZHU Lei, HAO Dandan.
Research progress on non-coding RNAs in the regulation of ferroptosis mediated sorafenib resistance in hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2025, 39(3): 256-261.
|
| [2] |
ZHANG Kangjun, FANG Taishi, CEN Fulan, YAN Xu, CHEN Qijun, MA Nan.
circ_0008043 promotes glycolysis of hepatocellular carcinoma and the development of hepatocellular carcinoma through miR-198/SLC2A1 axis
[J]. Journal of Practical Oncology, 2024, 38(6): 388-401.
|
| [3] |
GUAN Yongyu, NIE Hao, ZHANG Chong.
Research progress of hepatocellular carcinoma mouse models
[J]. Journal of Practical Oncology, 2024, 38(5): 342-348.
|
| [4] |
WU Dongyang, CAI Qingshan, LIU Dong, ZUO Ganggang, LI Shudong, LIU Liyou, ZHENG Jianxing.
The effects and mechanism of long non-coding RNA CASC15 on proliferation,invasion and migration of hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2024, 38(1): 18-29.
|
| [5] |
PANG Wu, CHEN Lijiang, ZHU Yu, WU Yakun, ZHANG Wei.
The expression of serum miRNA-24 and miRNA-509 in patients with hepatocellular carcinoma and their correlation with prognosis
[J]. Journal of Practical Oncology, 2023, 37(5): 411-415.
|
| [6] |
CUI Yongkang, YU Chengping, XU Haozhi, MA Xinyu, MA Yong, LI Linqiang.
Effects of nutritional risk index in predicting postoperative complications and prognosis of patients with resectable hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2023, 37(3): 243-251.
|
| [7] |
YIN Dingwei, JING Jie.
Research progress on the role of Gut microbiota in hepatocellular carcinoma and its therapeutic application
[J]. Journal of Practical Oncology, 2023, 37(3): 281-286.
|
| [8] |
LIU Jing, CHU Yanjie, PEI Fenghua, XU Ruiling, WANG Yanbo.
Role and mechanism of lncRNA AP000487.1 in esophageal cancer
[J]. Journal of Practical Oncology, 2023, 37(2): 123-129.
|
| [9] |
WANG Jiabei, ZHANG Yunguang, LIU Lianxin.
Clinical efficacy and safety analysis of immunotherapy combined with molecularly targeted drugs in the treatment of advanced hepatocellular carcinoma:A single-arm retrospective study
[J]. Journal of Practical Oncology, 2022, 36(6): 489-494.
|
| [10] |
LIU Jia, YANG Daokun, WANG Yanping, CHEN Baoxin, WANG Xinwei, SHEN Jiao.
Research status of biomarkers related to the efficacy of PD-1 inhibitors in the treatment of hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2022, 36(4): 374-380.
|
| [11] |
LIU Jiaming, CUI Yifeng, LU Zhaoyang.
Aqueous Huaier extract inhibits the proliferation and metastasis of hepatocellular carcinoma by regulating the Akt signaling pathway through mitochondrial transcription factor A
[J]. Journal of Practical Oncology, 2022, 36(3): 203-207.
|
| [12] |
PANG Chunhua, LI Fanrong, TANG Rubing, QIN Lei, ZHAO Xinhua, TANG Juan, YOU Xuemei.
Association between preoperative fatigue status and postoperative quality of life in patients with advanced hepatocellular carcinoma:a prospective cohort study
[J]. Journal of Practical Oncology, 2022, 36(2): 127-132.
|
| [13] |
LIU Yu, YU Xingxin, GENG Zhida, CHEN Zhengliang, HUI Peng, LIANG Yingjian.
The role of liver fibroblasts in the occurrence and development of hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2022, 36(2): 167-172.
|
| [14] |
WANG Zongwen, LI Xiaodong, ZHU Qiankun, ZENG Shicong, ZHAI Bo.
KIF14 in the mechanism of acquired drug resistance in hepatocellular carcinoma SMCC-7721 cells
[J]. Journal of Practical Oncology, 2022, 36(1): 14-19.
|
| [15] |
LIU Fei, SUI Hong.
Research progress in molecular classification of liver cancer based on tumor immunological microenvironment
[J]. Journal of Practical Oncology, 2021, 35(6): 557-561.
|